|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Paller, Amy S.; Siegfried, Elaine C.; Cork, Michael J.; Wollenberg, Andreas; Arkwright, Peter D.; Gonzalez, Mercedes E.; Lockshin, Benjamin; Chen, Zhen; Bansal, Ashish; Levit, Noah A. und Prescilla, Randy
(2022):
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis.
In: Pediatric Drugs, Bd. 25, Nr. 1: S. 67-77
Paller, Amy S.; Simpson, Eric L.; Siegfried, Elaine C.; Cork, Michael J.; Wollenberg, Andreas; Arkwright, Peter D.; Soong, Weily; Gonzalez, Mercedes E.; Schneider, Lynda C.; Sidbury, Robert; Lockshin, Benjamin; Meltzer, Steven; Wang, Zhixiao; Mannent, Leda P.; Amin, Nikhil; Sun, Yiping; Laws, Elizabeth; Akinlade, Bolanle; Dillon, Myles; Kosloski, Matthew P.; Kamal, Mohamed A.; Dubost-Brama, Ariane; Patel, Naimish; Weinreich, David M.; Yancopoulos, George D.; O'Malley, John T. und Bansal, Ashish
(2022):
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
In: Lancet, Bd. 400, Nr. 10356: S. 908-919
Alexis, Andrew F.; Rendon, Marta; Silverberg, Jonathan I.; Pariser, David M.; Lockshin, Benjamin; Griffiths, Christopher E. M.; Weisman, Jamie; Wollenberg, Andreas; Chen, Zhen; Davis, John D.; Li, Meng; Eckert, Laurent; Gadkari, Abhijit; Shumel, Brad; Rossi, Ana B.; Graham, Neil M. H. und Ardeleanu, Marius
(2019):
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials.
In: Journal of Drugs in Dermatology, Bd. 18, Nr. 8: S. 804-813